4.4 Article

Risk Factors Related to a Hospital-Associated Cluster of Clostridium difficile PCR Ribotype 027 Infections in Germany During 2007

期刊

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
卷 30, 期 3, 页码 282-284

出版社

CAMBRIDGE UNIV PRESS
DOI: 10.1086/594367

关键词

-

向作者/读者索取更多资源

In 2007, Clostridium difficile polymerase chain reaction (PCR) ribotype 027 emerged in Germany. We conducted a hospital-based case-control study to identify specific risk factors for infection with this strain. Logistic regression analysis involving 15 case patients and 31 control patients revealed that exposure to fluoroquinolones ( matched odds ratio, 36.2; P < .01) or cephalosporins (matched odds 19.1; P < .01) was independently related to C. difficile PCR ribotype 027 infection.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemical Research Methods

Establishment of an anti-hepatitis C virus IgG avidity test for dried serum/plasma spots

Amare Eshetu, Andrea Hauser, Matthias an der Heiden, Daniel Schmidt, Karolin Meixenberger, Stefan Ross, Martin Obermeier, Robert Ehret, Claus-Thomas Bock, Barbara Bartmeyer, Viviane Bremer, Norbert Bannert

JOURNAL OF IMMUNOLOGICAL METHODS (2020)

Article Public, Environmental & Occupational Health

Evaluation of the German surveillance system for hepatitis B regarding timeliness, data quality, and simplicity, from 2005 to 2014

L. Boes, C. Houareau, D. Altmann, M. An Der Heiden, V Bremer, M. Diercke, S. Dudareva, A. Neumeyer-Gromen, R. Zimmermann

PUBLIC HEALTH (2020)

Article Public, Environmental & Occupational Health

Prevalence of patients with HIV receiving outpatient medical care in Germany-an analysis based on secondary data

Diana Kurch-Bek, Christian Gallowitz, Axel Baumgarten, Bernhard Tenckhoff, Matthias an der Heiden

BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ (2020)

Article Immunology

Invasive Haemophilus influenzae Infections in Germany After the Introduction of Routine Childhood Immunization, 2001-2016

Anja Takla, Viktoria Schoenfeld, Heike Claus, Manuel Krone, Matthias an der Heiden, Judith Koch, Ulrich Vogel, Ole Wichmann, Thien-Tri Lam

OPEN FORUM INFECTIOUS DISEASES (2020)

Article Infectious Diseases

Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020

Sarah K. Norgaard, Lasse S. Vestergaard, Jens Nielsen, Lukas Richter, Daniela Schmid, Natalia Bustos, Toon Braye, Maria Athanasiadou, Theodore Lytras, Gleb Denissov, Tatjana Veideman, Oskari Luomala, Teemu Mottonen, Anne Fouillet, Celine Caserio-Schonemann, Matthias an der Heiden, Helmut Uphoff, Kassiani Gkolfinopoulou, Janos Bobvos, Anna Paldy, Naama Rotem, Irene Kornilenko, Lisa Domegan, Joan O'Donnell, Francesca De Donato, Matteo Scortichini, Patrick Hoffmann, Telma Velez, Kathleen England, Neville Calleja, Liselotte van Asten, Lenny Stoeldraijer, Richard A. White, Trine H. Paulsen, Susana P. Silva, Ana P. Rodrigues, Petra Klepac, Metka Zaletel, Mario Fafangel, Amparo Larrauri, Inmaculada Leon, Ahmed Farah, Ilias Galanis, Christoph Junker, Damir Perisa, Mary Sinnathamby, Nick Andrews, Mark G. O'Doherty, David Irwin, Sharon Kennedy, Jim McMenamin, Cornelia Adlhoch, Nick Bundle, Pasi Penttinen, Jukka Pukkila, Richard Pebody, Tyra G. Krause, Kare Molbak

Summary: The EuroMOMO network monitors excess mortality in 27 European countries, with the first wave of the COVID-19 pandemic in 2020 resulting in high levels of excess mortality. Currently, there is a new surge in COVID-19 cases in Europe leading to substantial excess all-cause mortality observed by EuroMOMO.

EUROSURVEILLANCE (2021)

Article Medicine, General & Internal

The COVID-19 Disease Burden in Germany in 2020

Alexander Rommel, Elena von der Lippe, Dietrich Plass, Thomas Ziese, Michaela Diercke, Matthias an der Heiden, Sebastian Haller, Annelene Wengler

Summary: The COVID-19 pandemic posed significant challenges to the healthcare sector in 2020, with the burden of disease being calculated in terms of years of life lost. In Germany in 2020, 305,641 years of life were lost to COVID-19, with the majority attributed to death. Men lost more years of life than women due to the virus.

DEUTSCHES ARZTEBLATT INTERNATIONAL (2021)

Article Public, Environmental & Occupational Health

Monitoring of COVID-19 by extending existing surveillance for acute respiratory infections

Luise Goerlitz, Kristin Tolksdorf, Udo Buchholz, Kerstin Prahm, Ute Preuss, Matthias an der Heiden, Thorsten Wolff, Ralf Duerrwald, Andreas Nitsche, Janine Michel, Walter Haas, Silke Buda

Summary: Germany has established surveillance systems for national influenza pandemic preparedness to monitor the epidemiology of acute respiratory infections, circulating viruses, and trends. With the onset of the COVID-19 pandemic, these systems have been expanded to include monitoring of SARS-CoV-2 infections through GrippeWeb, Influenza Working Group, and ICOSARI systems. These systems enable monitoring of acute respiratory infections at different levels and provide important information on disease severity frequency in the population.

BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ (2021)

Article Infectious Diseases

SARS-CoV-2 variant B.1.1.7 susceptibility and infectiousness of children and adults deduced from investigations of childcare centre outbreaks, Germany, 2021

Anna Loenenbach, Inessa Markus, Ann-Sophie Lehfeld, Matthias an der Heiden, Walter Haas, Maya Kiegele, Andre Ponzi, Barbara Unger-Goldinger, Cornelius Weidenauer, Helen Schlosser, Alexander Beile, Udo Buchholz

Summary: The investigation of three SARS-CoV-2 variant B.1.1.7 childcare centre and related household outbreaks revealed similar secondary attack rates (SAR) among children and adults, suggesting a convergence in susceptibility and infectiousness between the two groups. This indicates a need to revisit public health measures accordingly.

EUROSURVEILLANCE (2021)

Article Public, Environmental & Occupational Health

Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019

Anna Maisa, Christian Kollan, Matthias an der Heiden, Florian van Bommel, Markus Cornberg, Stefan Mauss, Heiner Wedemeyer, Daniel Schmidt, Sandra Dudareva

Summary: Between 2008 and 2019, the number of chronic hepatitis B patients treated in Germany has increased steadily while the costs of nucleos(t)ide analogs therapy have decreased. Internal medicine specialists were the main prescribers, with the highest prescription rates in Berlin and Hamburg.

FRONTIERS IN PUBLIC HEALTH (2021)

Article Public, Environmental & Occupational Health

Household clusters reveal household- and variant-specific properties of SARS-CoV-2

Udo Buchholz, Kai Schulze-Wundling, Matthias an der Heiden

Summary: This study analyzed the transmission of COVID-19 within households and found that 95% of secondary cases had symptom onset within 14 days after the symptom onset of the primary case. The interval between symptom onsets decreased with different variants. The findings suggest that a 10-day household quarantine after symptom onset of the primary case is sufficient for COVID-free household contacts during dominant delta circulation.

EPIDEMIOLOGY AND INFECTION (2022)

Letter Public, Environmental & Occupational Health

Serial interval in households infected with SARS-CoV-2 variant B.1.1.529 (Omicron) is even shorter compared to Delta

Matthias an der Heiden, Udo Buchholz

EPIDEMIOLOGY AND INFECTION (2022)

Article Microbiology

Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany-Results from the SeBluCo Study 2020-2022

Ruth Offergeld, Karina Preussel, Thomas Zeiler, Konstanze Aurich, Barbara I. Baumann-Baretti, Sandra Ciesek, Victor M. Corman, Viktoria Dienst, Christian Drosten, Siegfried Goerg, Andreas Greinacher, Marica Grossegesse, Sebastian Haller, Hans-Gert Heuft, Natalie Hofmann, Peter A. Horn, Claudia Houareau, Ilay Guelec, Carlos Luis Jimenez Klingberg, David Juhl, Monika Lindemann, Silke Martin, Hannelore K. Neuhauser, Andreas Nitsche, Julia Ohme, Sven Peine, Ulrich J. Sachs, Lars Schaade, Richard Schaefer, Heinrich Scheiblauer, Martin Schlaud, Michael Schmidt, Markus Umhau, Tanja Vollmer, Franz F. Wagner, Lothar H. Wieler, Hendrik Wilking, Malte Ziemann, Marlow Zimmermann, Matthias an der Heiden

Summary: SARS-CoV-2 serosurveillance is crucial for infection control measures and understanding underreporting. A study in Germany analyzed blood donor samples collected from April 2020 to April 2021, September 2021, and April/May 2022. The seroprevalence of SARS-CoV-2 increased over time, reaching 100% in April/May 2022. Neutralizing capacity was also observed in the majority of positive specimens. The study revealed low levels of underreporting, indicating an effective testing and notification system in Germany.

PATHOGENS (2023)

Article Biology

Prevalence of hepatitis C in the adult population of Bulgaria: a pilot study

Ida Sperle, Stine Nielsen, Martyna Gassowski, Zlatina Naneva, Tanya Perchemlieva, Andrew Amato-Gauci, Matthias an der Heiden, Viviane Bremer, Elitsa Golkocheva-Markova, Kristiyan Hristov, Elena Kaneva, Yanita Simeonova, Tencho Tenev, Tonka Varleva, Erika Duffell, Ruth Zimmermann

BMC RESEARCH NOTES (2020)

Article Public, Environmental & Occupational Health

Are men who have sex with men in Europe protected from hepatitis B?

M. Brandl, A. J. Schmidt, U. Marcus, M. an der Heiden, S. Dudareva

EPIDEMIOLOGY AND INFECTION (2020)

Article Public, Environmental & Occupational Health

Implications of a change in case definition and screening of asylum seekers for hepatitis B surveillance in Germany in 2015 and 2016

A. von Laer, M. Diercke, M. an der Heiden, D. Altmann, R. Zimmermann, S. Dudareva

EPIDEMIOLOGY AND INFECTION (2020)

暂无数据